BeyondSpring announces leadership transition effective July 1, 2026
Min Qiu appointed CEO to execute DUBLIN-4 Phase 3 program for Plinabulin; Na Li named CFO. Leadership changes align organizational structure with confirmatory trial pathway and IP portfolio extending through 2041 with potential patent extension.
View filing at SEC.gov →